Edwards Lifesciences Corporation
- EW
- NYSE
- Medical devices
- Structural Heart Devices
- Patient Monitoring
$86.60
Today −1.70%Quote Oct 16, 2026, 08:00 PM UTC
−1.87%over the last month
Max drawdown −5.1%From 1-month high −2.5%3 months +1.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$49.90B
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$102.44
+18.3% from here
Floor
$85.25
1.6% below price
Where the price sits
49 analysts
Analyst range, low to high
$85.00$110.00
- Price $86.60
- Resistance $87.61–$88.49
- Consensus $102.44
The price is just above its floor and right under resistance. Analysts' average target sits about 18% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about EWPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $1.74B
- Transcatheter Aortic Valve Replacement$1.26B72.3%
- Surgical$284.1M16.3%
- Transcatheter Mitral and Tricuspid Therapies$198.6M11.4%
Industry
Medical devices
Employees
16,000
Founded
1958